The PK/PD index (CMAX/MIC) for ciprofloxacin in patients with cystic fibrosis

Acta Poloniae Pharmaceutica - Drug Research

Volumn 68, Issue 5, 2011, Pages 777-783

  Szałek, Edyta ^a   Kamińska, Agnieszka ^a   Goździk Spychalska, Joanna ^a   Grześkowiak, Edmund ^a   Batura Gabryel, Halina ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Ciprofloxacin; Cystic fibrosis; Pharmacokinetics

Indexed keywords

CIPROFLOXACIN; CIPRONEX; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ALPHA HEMOLYTIC STREPTOCOCCUS; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CYSTIC FIBROSIS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KLEBSIELLA OXYTOCA; MALE; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; PHARMACOKINETICS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; ADULT; ALGORITHM; BACTERICIDAL ACTIVITY; BACTERIUM; DRUG EFFECT; DRUG MONITORING; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; STATISTICAL MODEL;

ADULT; ALGORITHMS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BACTERIA; CIPROFLOXACIN; CYSTIC FIBROSIS; DRUG MONITORING; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MICROBIAL SENSITIVITY TESTS; MODELS, STATISTICAL; SERUM BACTERICIDAL TEST; YOUNG ADULT;

EID: 80054015962     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Scaglione F, Paraboni L. J.: Antimicrob. Agents 32, 294 (2008).
2. Roberts JA, Lipman J.: Crit. Care Med. 37, 840 (2009).
3. Castellani C., Southern K.W., Brownlee K., Dankert Roelse J., Duff A., Farrell M., Mehta A. et al.: J. Cyst. Fibros. 8, 153 (2009).
4. http://www.cfww.org/docs/who/2002/who-report-classification-of-cf-and- related-disord.pdf (1 July 2010).
5. Lindsay C.A., Bosso J.A.: Clin. Pharmacokinet. 24, 496 (1993).
6. Touw D.J., Vinks A.A., Mouton J.W., Horrevorts A.M.: Clin. Pharmacokinet. 35, 437 (1998).
7. Touw D.J.: Pharm. World Sci. 20, 149 (1998).
8. Rey E., Tréluyer J.M., Pons G.: Clin. Pharmacokinet. 35, 313 (1998).
9. Montgomery M.J., Beringer P.M., Aminimanizani A., Louie S.G., Shapiro B.J., Jelliffe R., Gill M.A.: Antimicrob. Agents Chemother. 45, 3468 (2001).
10. Cantón R., Cobos N., de Gracia J., Baquero F., Honorato J., Gartner S., Alvarez A. et al.: Clin. Microbiol. Infect. 11, 690 (2005).
11. Bilton D., Henig N., Morrissey B., Gotfried M.: Chest 130, 1503 (2006).
12. Scaglione F., Paraboni L.: Expert Rev. Anti. Infect. Ther. 4, 479 (2006).
13. Scaglione F.: Int. J. Antimicrob. Agents 19, 349 (2002).
14. Cockcroft D.W., Gault M.H.: Nephron 16, 31 (1976).
15. Hassan Y., Alfadly S.O., Azmin M.N., Peh K.K., Tan T.F., Noorizan A.A., Ismail O.: Singapore Med. J. 48, 819 (2007).
16. Conil J.M., Georges B., de Lussy A., Khachman D., Seguin T., Ruiz S., Cougot P. et al.: Int. J. Antimicrob. Agents 32, 505 (2008).
17. Maya M.T., Goncalves N.J., Silva N.B., Morais J.A.: J. Chromatogr. B 755, 305 (2001).
18. Sawchuk R.J., Zaske D.E.: J. Pharmacokinet. Biopharm. 4, 183 (1976).
19. Mohr J.F., Wanger A., Rex J.H.: Diagn. Microbiol. Infect. Dis. 48, 125 (2004).
20. Mouton J.W., Dudley M.N., Cars O., Derendorf H., Drusano G.L.: J. Antimicrob. Chemother. 55, 601 (2005).
21. Prandota J.: Drugs. 35, 542 (1988).
22. Mimeault J., Vallée F., Seelmann R., Sörgel F., Ruel M., LeBel M.: Clin. Pharmacol. Ther. 47, 618 (1990).
23. Payen S., Serreau R., Munck A., Aujard Y., Aigrain Y., Bressolle F., Jacqz-Aigrain E.: Antimicrob. Agents Chemother. 47, 3170 (2003).
24. Santos R.P., Prestidge C.B., Brown M.E., Urbancyzk B., Murphey D.K., Salvatore C.M., Jafri H.S.et al.: Pediatr Pulmonol. 44, 148 (2009).
25. Odoul F., Le Guellec C., Giraut C., de Gialluly C., Marchand S., Paintaud G., Saux M.C. et al.: Therapie 56, 519 (2001).
26. Forrest A., Ballow C.H., Nix D.E., Birmingham M.C., Schentag J.J.: Antimicrob. Agents Chemother. 37, 1065 (1993).
27. Preston S.L., Drusano G.L., Berman A.L., Fowler C.L., Chow A.T., Dornseif B., Reichl V. et al.: JAMA 279, 125 (1998).
28. Sánchez Navarro M.D., Sayalero Marinero M.L., Sánchez Navarro A.: J. Antimicrob. Chemother. 50, 67 (2002).
29. van Zanten A.R., Polderman K.H., van Geijlswijk I.M., van der Meer G.Y., Schouten M.A., Girbes A.R.: J. Crit. Care 23, 422 (2008).